NTRS vs NVCT · P/E 18, rev $2.69B vs $304.5M cap
Northern Trust Corporation (NTRS) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
NVCT does not have a complete income-statement cache yet.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the NTRS and NVCT stock pages for the full models.
Not investment advice.